Q1 FY27 results approved; board clears 1.782 MW solar project plan

Results View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.3%Reaction day

₹112.60

prior close

₹113.85

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.1%-2.3% vs market

Pharmaceuticals peers, median of 165sector-0.1%-2.3% vs sector

On the reaction day the stock moved 2.3 pts less than Nifty Microcap 250 and 2.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.3-0.1-2.3-0.1-2.3

Next day

-1.4-0.2-1.2+0.0-1.5

-2.3+0.1-2.5-0.0-2.3

-2.8+0.3-3.1+0.3-3.1

+1.0+0.4+0.6-0.6+1.6

-2.3+0.5-2.8-1.1-1.2

-1.4+0.3-1.7-2.0+0.6

15d

-0.2+1.9-2.0+0.2-0.4

-3.2+2.2-5.4+1.7-4.9

+0.1-1.2+1.3-2.0+2.2

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved unaudited standalone and consolidated results for Q1 FY27 (quarter ended June 30, 2026). Auditors Srinaga and Giridharan issued an unqualified limited review report. Authority was delegated to the MD and Executive Director for incorporating wholly owned subsidiaries. Additionally, the board cleared a 1.782 MW grid-connected rooftop solar PV project under the RESCO/OPEX model, marking an entry into the renewable energy sector.

Likely market impact

Neutral to mildly positive; new solar venture may diversify income. Actual financial numbers not visible in filing.